Vidipha Central Pharmaceutical JSC (VDP) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Vidipha Central Pharmaceutical JSC

Why is Vidipha Central Pharmaceutical JSC ?

Flat results in Sep 25

ROCE(HY) Lowest at 8.37%
INTEREST(Q) At VND 3,135.14 MM has Grown at 26.15%
RAW MATERIAL COST(Y) Grown by 45.94% (YoY)

With ROE of 9.08%, it has a fair valuation with a 0.00 Price to Book Value

Over the past year, while the stock has generated a return of 44.93%, its profits have risen by 0.1%

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Vidipha Central Pharmaceutical JSC should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Vidipha Central Pharmaceutical JSC for you?

High Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Vidipha Central Pharmaceutical JSC

44.93%

1.12

44.51%

Vietnam VN Ho Chi Minh Index

43.59%

1.93

22.62%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

11.58%

EBIT Growth (5y)

10.05%

EBIT to Interest (avg)

4.71

Debt to EBITDA (avg)

0.68

Net Debt to Equity (avg)

-0.20

Sales to Capital Employed (avg)

1.00

Tax Ratio

20.61%

Dividend Payout Ratio

76.87%

Pledged Shares

Institutional Holding

ROCE (avg)

11.37%

ROE (avg)

10.13%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

EV to EBIT

-1.43

EV to EBITDA

-1.03

EV to Capital Employed

-0.18

EV to Sales

-0.12

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

9.08%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

Bullish

Bearish

Bollinger Bands

Mildly Bullish

Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Bearish

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

13What is working for the Company

OPERATING CASH FLOW(Y)

Highest at VND 119,498.57 MM

DEBTORS TURNOVER RATIO(HY)

Highest at 5.69 times

CASH AND EQV(HY)

Highest at VND 692,900.74 MM

INVENTORY TURNOVER RATIO(HY)

Highest at 2.48 times

NET SALES(Q)

Highest at VND 358,641.46 MM

-14What is not working for the Company

ROCE(HY)

Lowest at 8.37%

INTEREST(Q)

At VND 3,135.14 MM has Grown at 26.15%

RAW MATERIAL COST(Y)

Grown by 45.94% (YoY

OPERATING PROFIT(Q)

Lowest at VND 19,589.41 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 5.46 %

PRE-TAX PROFIT(Q)

Lowest at VND 15,175.3 MM

NET PROFIT(Q)

Lowest at VND 11,991.54 MM

EPS(Q)

Lowest at VND 543.01

Here's what is working for Vidipha Central Pharmaceutical JSC

Net Sales

At VND 358,641.46 MM has Grown at 68.01%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very positive

Net Sales (VND MM)

Debtors Turnover Ratio

Highest at 5.69 times and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Operating Cash Flow

Highest at VND 119,498.57 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (VND MM)

Net Sales

Highest at VND 358,641.46 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (VND MM)

Cash and Eqv

Highest at VND 692,900.74 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Inventory Turnover Ratio

Highest at 2.48 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Depreciation

At VND 5,674.31 MM has Grown at 64.02%

period on period (QoQ)

MOJO Watch

The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (VND MM)

Here's what is not working for Vidipha Central Pharmaceutical JSC

Interest

At VND 3,135.14 MM has Grown at 26.15%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (VND MM)

Operating Profit

Lowest at VND 19,589.41 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (VND MM)

Operating Profit Margin

Lowest at 5.46 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit

Lowest at VND 15,175.3 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (VND MM)

Net Profit

Lowest at VND 11,991.54 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (VND MM)

EPS

Lowest at VND 543.01

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (VND)

Raw Material Cost

Grown by 45.94% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales